Sheldon Koenig, MBA

Organizer
DISC Type : Sd

Board Member & Co-Founder at Nuvig Therapeutics Inc.

Washington, District of Columbia, United States

Overview

Sheldon Koenig is the President and CEO of Esperion and a Co-Founder of Nuvig Therapeutics. With over two decades of executive experience at Merck and Sanofi, he specializes in global marketing, commercialization, and market access for biotech innovations. People who have worked with him describe him as a "smart" and "savvy" marketer.

He is dedicated to advancing the pharmaceutical industry and expressed a desire for professionals in the field to continue bringing great medicine and research forward. He values a collaborative team approach and engaging with both current and future investors to share compelling company stories.

He has deep expertise in managing all phases of clinical trials (I-V) and possesses extensive knowledge of U. S. reimbursement and global payor strategies.

Personality Overview

Strong-minded

Trusting Of Others

Pleasant

They exhibit a rare combination of being result-oriented but patient at the same time.  They might take some time to make their mind up but once they do, they don't change it easily. Reading between the lines and seeing beyond your words comes naturally to them.

Topics They Care About

Biotech Commercialization
His career focuses on propelling product innovation, market access, and sales growth for pharma and biotech companies on a global scale.
Cardiovascular Health
As CEO of Esperion, he leads a company focused on developing and commercializing medicines for patients with elevated LDL-C and cardiovascular disease.
Investor Relations
He frequently speaks about the rewarding experience of engaging with current and future investors and sharing his company's compelling story at events like the JP Morgan conference.

Media Appearances

Sheldon Koenig, MBA - Nuvig Therapeutics Inc.. Featured in TheOrg.com

See Now

Work History

11-2021
Board Member & Co-Founder at Nuvig Therapeutics Inc.
5-2021
President and CEO of Esperion Therapeutics at Esperion
12-2020 - 5-2021
Chief Operating Officer at Esperion
1-2019 - 8-2020
Executive Vice President and Chief Commercial Officer at Portola Pharmaceuticals
7-2018 - 12-2018
President at SL Koenig & Associates, LLC

Education

Bachelor of Applied Science (B.A.Sc.) from Drexel University
MBA from Monmouth University

More Information

Social Presence :

Prographics :

Exp : 9 Location : Washington, District of Columbia, United States Job Level : Leadership Designation : Board Member & Co-Founder at Nuvig Therapeutics Inc.
URL has been copied!

Insights For Selling To Sheldon

During A Call Or A Meeting

DO's

  • Focus on the results that your product produces, expect some strategic questions in return
  • Suggest clear next steps with confidence, don't be vague or hesitant
  • Stick to your standard pitch and qualifying script, don't try to wing it

DONT's

  • Don't focus too much on mutual contacts or bother about other stakeholders, focus on them
  • Don't go over them unless you are left with no other option
  • Don't shy away from asking hard questions, but be extra polite

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Sheldon is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Sheldon

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Sheldon move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Sheldon take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Sheldon

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.